These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8642873)

  • 1. A mutant form of p135tyk2, an interferon-alpha inducible tyrosine kinase, suppresses the transformed phenotype of Daudi cells.
    Davis E; Krishnan K; Yan H; Newcomb EW; Krolewski JJ
    Leukemia; 1996 Mar; 10(3):543-51. PubMed ID: 8642873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor.
    Colamonici OR; Uyttendaele H; Domanski P; Yan H; Krolewski JJ
    J Biol Chem; 1994 Feb; 269(5):3518-22. PubMed ID: 8106393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
    Colamonici O; Yan H; Domanski P; Handa R; Smalley D; Mullersman J; Witte M; Krishnan K; Krolewski J
    Mol Cell Biol; 1994 Dec; 14(12):8133-42. PubMed ID: 7526154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway.
    Watling D; Guschin D; Müller M; Silvennoinen O; Witthuhn BA; Quelle FW; Rogers NC; Schindler C; Stark GR; Ihle JN
    Nature; 1993 Nov; 366(6451):166-70. PubMed ID: 7901766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
    Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
    Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyk2 is essential for IFN-alpha-induced gene expression in mast cells.
    Mori Y; Hirose K; Suzuki K; Nakajima H; Seto Y; Ikeda K; Shimoda K; Nakayama K; Saito Y; Iwamoto I
    Int Arch Allergy Immunol; 2004 Jun; 134 Suppl 1():25-9. PubMed ID: 15166480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction.
    Velazquez L; Mogensen KE; Barbieri G; Fellous M; Uzé G; Pellegrini S
    J Biol Chem; 1995 Feb; 270(7):3327-34. PubMed ID: 7531704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-kappaB pathway and interferon-beta/tyrosine kinase 2/Janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid.
    Kim HJ; Tsoyi K; Heo JM; Kang YJ; Park MK; Lee YS; Lee JH; Seo HG; Yun-Choi HS; Chang KC
    J Pharmacol Exp Ther; 2007 Feb; 320(2):782-9. PubMed ID: 17108235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytes.
    Potla R; Koeck T; Wegrzyn J; Cherukuri S; Shimoda K; Baker DP; Wolfman J; Planchon SM; Esposito C; Hoit B; Dulak J; Wolfman A; Stuehr D; Larner AC
    Mol Cell Biol; 2006 Nov; 26(22):8562-71. PubMed ID: 16982690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for Janus kinases in crosstalk between ErbB3 and the interferon-alpha signaling complex in myeloma cells.
    Walters DK; Jelinek DF
    Oncogene; 2004 Feb; 23(6):1197-205. PubMed ID: 14647450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer.
    Mao X; Seidlitz E; Ghosh K; Murakami Y; Ghosh HP
    Cancer Res; 2003 Nov; 63(22):7979-85. PubMed ID: 14633730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
    Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
    J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase.
    Yan H; Piazza F; Krishnan K; Pine R; Krolewski JJ
    J Biol Chem; 1998 Feb; 273(7):4046-51. PubMed ID: 9461596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases.
    Yayon A; Ma YS; Safran M; Klagsbrun M; Halaban R
    Oncogene; 1997 Jun; 14(25):2999-3009. PubMed ID: 9223663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis.
    de Belle I; Huang RP; Fan Y; Liu C; Mercola D; Adamson ED
    Oncogene; 1999 Jun; 18(24):3633-42. PubMed ID: 10380885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
    Zhang L; Kharbanda S; Hanfelt J; Kern FG
    Cancer Res; 1998 Jan; 58(2):352-61. PubMed ID: 9443417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TYK2 is a key regulator of the surveillance of B lymphoid tumors.
    Stoiber D; Kovacic B; Schuster C; Schellack C; Karaghiosoff M; Kreibich R; Weisz E; Artwohl M; Kleine OC; Muller M; Baumgartner-Parzer S; Ghysdael J; Freissmuth M; Sexl V
    J Clin Invest; 2004 Dec; 114(11):1650-8. PubMed ID: 15578097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immortalized mammary epithelial cells overexpressing protein kinase C gamma acquire a malignant phenotype and become tumorigenic in vivo.
    Mazzoni E; Adam A; Bal de Kier Joffe E; Aguirre-Ghiso JA
    Mol Cancer Res; 2003 Aug; 1(10):776-87. PubMed ID: 12939403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
    Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
    Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.